- Home
- TPR vs EXAS Comparison
TPR vs EXAS Comparison
Compare TPR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPR
- EXAS
- Stock Information
- Founded
- TPR 1941
- EXAS 1995
- Country
- TPR United States
- EXAS United States
- Employees
- TPR N/A
- EXAS N/A
- Industry
- TPR Apparel
- EXAS Medical Specialities
- Sector
- TPR Consumer Discretionary
- EXAS Health Care
- Exchange
- TPR Nasdaq
- EXAS Nasdaq
- Market Cap
- TPR 17.5B
- EXAS 10.7B
- IPO Year
- TPR 2000
- EXAS N/A
- Fundamental
- Price
- TPR $98.32
- EXAS $51.91
- Analyst Decision
- TPR Buy
- EXAS Strong Buy
- Analyst Count
- TPR 18
- EXAS 20
- Target Price
- TPR $85.11
- EXAS $70.26
- AVG Volume (30 Days)
- TPR 3.8M
- EXAS 2.8M
- Earning Date
- TPR 08-14-2025
- EXAS 07-30-2025
- Dividend Yield
- TPR 1.42%
- EXAS N/A
- EPS Growth
- TPR 0.55
- EXAS N/A
- EPS
- TPR 3.79
- EXAS N/A
- Revenue
- TPR $6,878,600,000.00
- EXAS $2,828,128,000.00
- Revenue This Year
- TPR $5.39
- EXAS $14.58
- Revenue Next Year
- TPR $2.15
- EXAS $12.75
- P/E Ratio
- TPR $25.98
- EXAS N/A
- Revenue Growth
- TPR 2.67
- EXAS 11.57
- 52 Week Low
- TPR $35.23
- EXAS $39.97
- 52 Week High
- TPR $98.61
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- TPR 79.00
- EXAS 44.34
- Support Level
- TPR $84.39
- EXAS $52.00
- Resistance Level
- TPR $89.18
- EXAS $55.90
- Average True Range (ATR)
- TPR 2.44
- EXAS 2.31
- MACD
- TPR 1.01
- EXAS -0.04
- Stochastic Oscillator
- TPR 98.82
- EXAS 24.90
About TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounts for about 80% of its sales and more than 90% of its operating profit. Coach products are sold through 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade, which generated 54% of its sales from handbags in fiscal 2024. Kate Spade is known for its colorful patterns and graphics. Meanwhile, Tapestry's smallest brand, luxury footwear maker Stuart Weitzman, is set to be sold to Caleres in the summer of 2025.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.